PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

Topic

First-in-Class

First-in-class drug approvals, novel mechanisms of action, new drug class launches, and formulary and access implications for therapies with no prior-class precedent.

1 article·Lives underApprovals Pipeline·Last updated 2026-05-28

Approvals· May 28, 2026 · 7 min read

Baxfendy (baxdrostat) coverage guide: the first aldosterone synthase inhibitor for uncontrolled hypertension

By Ran Chen#Hypertension #Cardiovascular #FDA Approval